Breast cancer, with its global prevalence and impact on women's health, necessitates
effective early detection and accurate staging for optimal patient outcomes. Traditional …

Positron emission tomography (PET) plays a crucial role in breast cancer management. This
review addresses the role of PET imaging in breast cancer care. We focus primarily on the …

Breast cancer is a major disease with high morbidity and mortality in women worldwide.
Increased use of imaging biomarkers has been shown to add more information with clinical …

Positron-emission tomography-computed tomography (PET-CT) is widely used for breast
cancer staging when metastatic disease is suspected, as it provides both functional and …

Breast cancer is an international public health concern in which an optimal treatment plan
requires a precise staging. Both MRI and PET imaging techniques have made significant …

Over the past decade, the role of radiology in breast cancer has changed significantly
because of the technical advances in mammography, greater use of ultrasonography, and …

Molecular imaging of breast cancer can potentially be used for breast cancer screening,
staging, restaging, response evaluation and guiding therapies. Techniques for molecular …

Imaging is paramount for the early detection and clinical staging of breast cancer, as well as
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …

PET/MRI has been available since 2010, representing the newest of the hybrid imaging
modalities. It combines functional as well as morphologic high-resolution MRI data with …

Positron emission tomography/magnetic resonance imaging (PET/MRI) is an emerging
imaging technology that allows for the acquisition of multiple MRI parameters …